• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Investing

Planet Labs stock on edge ahead of earnings: will it drop 20%

by March 17, 2026
written by March 17, 2026

Planet Labs stock is stuck in a bear market after falling by 20% from its highest point this year.

PL was trading at $24.50, down from the year-to-date high of $30.85.

Its market capitalization has dropped from over $9 billion to the current $8.35 billion. So, will it rebound ahead of the upcoming earnings?

Planet Labs business is thriving 

Planet Labs PBC is a top company involved in earth observation solutions through low-orbit satellites. 

It designs, builds, and operates thousands of satellites and offers the services to government agencies and companies, including popular names like Bayer, AXA, and SwissRe.

Its images are used widely by media organizations like the New York Times, CNN, BBC, and Bloomberg.

Planet Labs stock has done well in the past few months, moving from last year’s low of $2.85 in April last year to the current $24.60. This growth happened as the its revenue growth accelerated, with the annual figure rising from $133 million in 2021 to $244 million last year.

The challenge, however, is that the company continues to lose money, with its net loss in the last five years rising to nearly $700 million.

Its most recent results showed that its revenue jumped by 33% in the third quarter to $81.3 million, with the percentage of the recurring annual contract rising to 97%. It has over 80% of the annual or multi-year contracts. Most notably, its backlog jumped to $734 million from $232 million in the same period a year earlier.

Planet Labs stock will be in the spotlight this week as it publishes its financial results.

Yahoo Finance data shows that the average estimate is that its revenue rose to $78 million in the last quarter, near the guidance of between $76 million and $80 million.

If this happens, the annual revenue will come in at $297 million, up by 22% YoY, followed by $377 million this year.

The company will likely continue generating double-digit growth in the coming years.

Most importantly, analysts believe that the company will move towards profitability. Its earnings-per-share is expected to come in at a loss of 11 cents last year followed by 7 cents this year.

A key challenge is that the company continues to face substantial competition from other satellite companies like Maxar, BlackSky, Capella Space, and Airbus Defense.

Planet Labs stock price technical analysis 

PL stock chart | Source: TradingView 

The daily timeframe chart shows that the PL stock price peaked at $30.93 in January this year and then pulled back to the current $24.60.

A closer look shows that the stock has formed an ascending channel whose support and resistance levels are its lowest and highest levels since February 3rd this year.

The stock has remained above the 50-day Exponential Moving Average (EMA), while the Relative Strength Index (RSI) has moved downwards from the overbought level of 86 to the current 50.

Therefore, the most likely Planet Labs stock outlook is bearish, with the next key target being the key support level at $19.70, its lowest level in February, which is about 20% below the current level.

On the flip side, a move above the key resistance level at $27.50 will invalidate the bearish outlook.

READ MORE: Samsung stock rises: can Nvidia revive its struggling foundry?

The post Planet Labs stock on edge ahead of earnings: will it drop 20% appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Gemini stock: Will Winklevoss Twins’ company crash below $5 after earnings?
next post
Europe bulletin: stocks rise, Bentley cuts jobs, Audi sees rebound

related articles

Top 3 catalysts for the Nikkei 225 Index...

April 27, 2026

Why is Sun Pharma betting $11.75B on a...

April 27, 2026

Hang Seng slips as Asian markets split; Nikkei,...

April 27, 2026

Meta, Microsoft earnings due next week: here’s what...

April 25, 2026

Evening digest: Google-Anthropic deal, DOJ drops probe against...

April 24, 2026

S&P 500, Nasdaq hit records; Dow slips as...

April 24, 2026

Nvidia replaced Intel in the Dow — today,...

April 24, 2026

X-Energy surges 36% in debut as $1B IPO...

April 24, 2026

Why is Skillz stock crashing despite major legal...

April 24, 2026

Lilly stock falls as Foundayo trails Novo’s Wegovy...

April 24, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump says officials who pushed climate change doomsday policies should be investigated: ‘Rewarded failure’

    November 19, 2025
  • China attacked US with hackers. We need to hit back hard

    December 16, 2024
  • House Dems push Garland to drop charges, release second part of Jack Smith report

    January 16, 2025
  • Bitcoin Nears $85K Amid Market Optimism

    April 21, 2025
  • Trump says US would strike again if Iran rebuilds nuclear program

    June 25, 2025

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025
  • 5

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024

Categories

  • Economy (829)
  • Editor's Pick (8,502)
  • Investing (2,063)
  • Stock (1,017)

Latest Posts

  • Iran’s supreme leader acknowledges thousands killed as Trump calls for new leadership: reports

    January 18, 2026
  • Trump’s massive 46% Vietnam tariffs could hit Nike, American Eagle and Wayfair

    April 3, 2025
  • Agenus stock plummets over 50% as FDA rejects accelerated approval for BOT/BAL cancer therapy

    July 18, 2024

Recent Posts

  • Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

    July 10, 2024
  • Frustration at Elon Musk spills over after closed-door House GOP meeting: ‘Fed to the wolves’

    February 25, 2025
  • Battleground Republicans hold the line as Johnson pressures Dems on shutdown

    October 17, 2025

Editor’s Pick

  • FLASHBACK: Wildest moments Mamdani overcame on the campaign trail to become NYC’s next mayor

    November 5, 2025
  • House GOP tensions erupt as Republicans turn on each other heading into year’s end

    December 16, 2025
  • Trump’s NIH director isn’t the only official wearing multiple hats during the president’s second term

    February 20, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock